Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms

Alberto M. Martelli,V Papa,Pierluigi Tazzari,Francesca Ricci,Cecilia Evangelisti,Francesca Chiarini,Cecilia Grimaldi,Alessandra Cappellini,G. Martinelli,Emanuela Ottaviani,Pasqualepaolo Pagliaro,S Horn,Jörg Bäsecke,L H Lindner,H. Eibl,James A. McCubrey

Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms

2010

Alberto M. Martelli
V Papa
Pierluigi Tazzari
Francesca Ricci
Cecilia Evangelisti
Francesca Chiarini
Cecilia Grimaldi
Alessandra Cappellini
G. Martinelli
Emanuela Ottaviani
Pasqualepaolo Pagliaro
S Horn
Jörg Bäsecke
L H Lindner
H. Eibl
James A. McCubrey

Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms

Keywords:

Myelogenous
Cancer research
Mitogen-activated protein kinase
Alkylphosphocholine
Hematology
Cytotoxic T cell
Cytotoxicity
Leukemia
Apoptosis
Internal medicine
Biology
Clonogenic assay
Cell culture
Cell cycle

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations